SCHEMBL25029309

SCHEMBL25029309

COCCN1CCC(Oc2ncc(-c3c[nH]c4c(C#N)cccc34)nc2C)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.40
▸ DYRK1A Q13627 2/20 0.40
▸ NFATC1 O95644 1/20 0.40
▸ CCNT1 O60563 2/20 0.38
▸ CCNK O75909 2/20 0.38
▸ CCNE1 P24864 2/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CDK9 P50750 2/20 0.38
▸ CDK12 Q9NYV4 2/20 0.38
▸ CDK7 P50613 1/20 0.38
▸ CCNH P51946 1/20 0.38
▸ MNAT1 P51948 1/20 0.38
▸ KRAS P01116 1/20 0.36
▸ PGR P06401 1/20 0.34
▸ LRRK2 Q5S007 2/20 0.34
▸ PDCD1 Q15116 1/20 0.34
▸ CD274 Q9NZQ7 1/20 0.34
▸ JAK1 P23458 4/20 0.34
▸ JAK2 O60674 2/20 0.34
▸ PIK3CD O00329 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29363578 1.00 GSK3B (0.40) GSK3BDYRK1ANFATC1CCNT1CCNK
SCHEMBL25029046 0.88 DYRK1A (0.45) GSK3BDYRK1ANFATC1CCNT1CCNK
SCHEMBL29364026 0.88 DYRK1A (0.45) GSK3BDYRK1ANFATC1CCNT1CCNK
SCHEMBL29364379 0.83 PIK3CD (0.46) GSK3BDYRK1ANFATC1PIK3CDPIK3CA
SCHEMBL25029217 0.83 PIK3CD (0.46) GSK3BDYRK1ANFATC1PIK3CDPIK3CA
SCHEMBL25027636 0.83 DYRK1A (0.43) GSK3BDYRK1ANFATC1CCNT1CCNK
SCHEMBL29364076 0.83 DYRK1A (0.43) GSK3BDYRK1ANFATC1CCNT1CCNK
SCHEMBL25028882 0.82 BTK (0.43) GSK3BDYRK1ANFATC1CDK7CCNH
SCHEMBL29364621 0.82 BTK (0.43) GSK3BDYRK1ANFATC1CDK7CCNH
SCHEMBL26719030 0.82 BTK (0.43) GSK3BDYRK1ANFATC1CDK7CCNH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed
US-11667624-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2023-06-06 — — US disclosed
US-11667624-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2023-06-06 — — US disclosed
EP-4182320-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS Nido Biosciences, Inc. (US) 2023-05-24 — — EP disclosed
CN-115996926-A Indole compounds as androgen receptor modulators 尼多生物科学有限公司 2023-04-21 — — CN disclosed
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 GSK3B 463/4885DYRK1A 1187/4885NFATC1 1397/4885
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 GSK3B 441/4885DYRK1A 1097/4885NFATC1 1359/4885
US-11667624-B2 Indole compounds as androgen receptor modulators AR, FSHR, ADRB3 GSK3B 468/4885DYRK1A 937/4885NFATC1 1507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback